LUNG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LUNG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Pulmonx's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.
For the Medical Devices subindustry, Pulmonx's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Pulmonx's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:
* The bar in red indicates where Pulmonx's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.
Pulmonx (NAS:LUNG) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation
EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Thank you for viewing the detailed overview of Pulmonx's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.
French Glendon E. Iii | director, officer: President and CEO | 700 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063 |
Geoffrey Beran Rose | officer: Chief Commercial Officer | 5124 ROCKWOOD PARKWAY NW, WASHINGTON DC 20016 |
John Mckune | officer: Interim CFO | 46668 CRAWFORD CT., FREMONT CA 94539 |
David Aaron Lehman | officer: General Counsel | C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
Derrick Sung | officer: Chief Financial Officer | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103 |
Alissa Hsu Lynch | director | 700 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063 |
Richard M Ferrari | director | 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050 |
Tiffany Sullivan | director | 700 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063 |
Boston Scientific Corp | 10 percent owner | 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234 |
Daniel P Florin | director | 56 E. BELL DRIVE, WARSAW IN 46581 |
Mead Dana G Jr. | director | 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Thomas William Burns | director | C/O GLAUKOS CORPORATION,, 26051 MERIT CIRCLE, SUITE 103, LAGUNA HILLS CA 92653 |
Georgia Melenikiotou | director | C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416 |
Staffan Lindstrand | director | C/O ODLANDER, FREDRIKSON & CO. AB, STRANDVAGEN 5B, STOCKHOLM V7 SE-114 51 |
From GuruFocus
By Business Wire Business Wire • 07-27-2022
By Sydnee Gatewood • 12-10-2021
By GuruFocusNews GuruFocusNews • 04-26-2022
By Marketwired • 07-26-2023
By GlobeNewswire GlobeNewswire • 12-29-2021
By GuruFocusNews GuruFocusNews • 02-10-2022
By Business Wire Business Wire • 04-18-2023
By GuruFocus Research • 12-23-2023
By Marketwired • 10-10-2023
By Marketwired • 08-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.